ArticleScience (New York, N.Y.)2021

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

Nir Drayman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.